Colorectal cancer screening through community pharmacies
Part of Cancer, Digestive system clinical trials.
This study looks at using community pharmacies to offer a simple stool test (called iFOBT) that can check for signs of colorectal cancer early. If you're in the age range and have not had recent tests, this might help you stay on top of your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 75 years old.
- You must be visiting a participating community pharmacy during the study period.
- You must be able to give your informed consent (agree to join) and fill out a questionnaire.
- You must agree to follow-up about a stool test (called iFOBT) - providing, completing, and getting results.
- You cannot have had colorectal cancer before, had a colonoscopy in the past year, have current colorectal cancer symptoms, or have a close family member with colorectal cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way to help people get recommended colorectal cancer screenings. If you are 45–75 and due for screening, you may receive information or support to help you decide and get tested.
This study collects data to improve how colorectal cancer is found and diagnosed. It compares new testing methods (like breath and stool tests) with standard colonoscopy in people with and without cancer or risk factors.
This study uses a simple blood test to find early signs of colorectal cancer in people who already had a positive stool test. If it works, it could help avoid unnecessary colonoscopies in the future.
This study helps patients at the Primary Care Medicine Clinic get screened for colorectal cancer using education and at-home stool tests. It aims to make screening easier and catch problems early.
This study tests if a stool microbiome test can help find colorectal cancer early in people who already had a positive FIT screening test. You would give a stool sample and your microbiome results will be compared to what the colonoscopy finds.
This trial tests a new stool-based screening test that may find colorectal cancer and advanced adenomas (precancerous growths) early. It studies whether the test works well compared with the standard colonoscopy, so it could offer an easier, less invasive screening option in the future.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.